Long-acting injectable malaria drug enters first-in-human study Calibr-Skaggs' long-acting injectable (LAI) platform transforms oral malaria treatment atovaquone, aiming for protection from malaria for three months.
January 23, 2025
LA JOLLA, CA The Calibr-Skaggs Institute for Innovative Medicines, the nonprofit drug development division of Scripps Research, designed a long-acting preventative medicine for malaria (CBE161 [MMV371]) that has been administered to the first cohort of healthy volunteers in a phase 1 clinical trial. The trial is sponsored by Medicines for Malaria Venture (MMV), the leading product development partnership for malaria drug research.
Scientists at Calibr-Skaggs discovered CBE161, which was then developed as MMV371 by MMV with support from Janssen Pharmaceuticals. MMV371 is now being tested in healthy volunteers at Quotient Sciences in Nottingham, UK, with a main objective of assessing its safety, tolerability and pharmacokinetics. If successful, MMV371 clinical trials in malaria-endemic countries will begin in 2026.
Atovaquone is a well-established antimalarial agent currently administered in combination with proguanil for the prevention of malaria for travelers to endemic regions. The combination, often marketed under the trade name Malarone , requires daily pills, and is not affordable in low- and middle-income countries.
MMV is developing MMV371 to ultimately be formulated in combination with a partner drug in line with the target product profile set for chemoprevention. As a long-acting injectable (LAI) therapy, it is designed to improve patient compliance and provide more consistent protection against malaria. Such an innovation would have a profound impact in regions with high malaria transmission.
The Calibr-Skaggs team selected atovaquone for LAI optimization since it is an approved malaria drug with favorable safety, tolerability and chemical properties. MMV371, if successful, represents a significant step forward in the fight against malaria, as it aims to meet the MMV target product profile of providing at least three months of protection with a single injection.
Our LAI platform transforms existing therapies into long-acting injectables, significantly improving patient compliance and extending protection, says Anil Gupta, director of medicinal chemistry at Calibr-Skaggs and a lead chemist on the discovery of CBE161. These long-acting therapies require less drug to be effective, reducing waste and cost, which is especially important in resource-limited areas.
To create the long-acting atovaquone analog CBE161, Gupta and his team tried several ways of extending atovaquone's time in circulation. As described in a recent preprint, they landed on a prodrug approach: This involves attaching a chemical group to the drug, which after injection is then removed by chemical or enzymatic processes in the body to reactivate the drug. They created several different prodrugs and tried various ways of delivering them. In an animal model, intramuscular (IM) injection of CBE161 maintained atovaquone levels above the minimal effective concentration for 69 days compared to 21 days with IM injection of atovaquone alone. These data indicate that CBE161 should extend the life of active atovaquone in the bloodstream of humans, enhancing its effectiveness with fewer injections.
For people in malaria-endemic regions, current chemoprevention therapies for malaria have strict, frequent dosing regimens that are difficult to adhere to providing opportunities for chemoresistance to evolve when not followed. MMV371 shows promise in extending protection with fewer doses and may also combat malaria resistance with a simpler administration schedule. Additionally, fewer doses could potentially reduce costs and enhance global malaria control efforts, particularly in high-prevalence, limited healthcare regions.
Because the LAI platform can expand access to effective therapies, we have the opportunity to leverage LAIs to treat multiple diseases and improve global health with lower-cost medicines that are easier to administer and meet patient needs, says Arnab Chatterjee, vice president of Medicinal Chemistry at Calibr-Skaggs. This is an exciting time for the LAI team at Calibr-Skaggs, as we have LAIs undergoing phase 1 clinical trials for both malaria and HIV.
About Scripps Research
Scripps Research is an independent, nonprofit biomedical institute ranked one of the most influential in the world for its impact on innovation by Nature Index. We are advancing human health through profound discoveries that address pressing medical concerns around the globe. Our drug discovery and development division, Calibr-Skaggs, works hand-in-hand with scientists across disciplines to bring new medicines to patients as quickly and efficiently as possible, while teams at Scripps Research Translational Institute harness genomics, digital medicine and cutting-edge informatics to understand individual health and render more effective healthcare. Scripps Research also trains the next generation of leading scientists at our Skaggs Graduate School, consistently named among the top 10 US programs for chemistry and biological sciences. Learn more at www.scripps.edu.
About the Calibr-Skaggs Institute for Innovative Medicines
The Calibr-Skaggs Institute for Innovative Medicines was founded on the principle that the creation of new medicines can be accelerated by pairing world-class biomedical research with state-of-the-art drug discovery and development capabilities. Leveraging the unique scientific framework of Scripps Research, Calibr-Skaggs has created a portfolio of drug candidates based on Scripps Research technologies and is shaping a new paradigm for advancing nonprofit biomedical research to impact patients. Learn more at calibr.scripps.edu.
About Medicines for Malaria Venture
Most recent headlines
09/11/2025
Dalet today announced a transformative leap forward for media operations: Agentic Artificial Intelligence (AI) that unifies the Dalet ecosystem under one natura...
16/10/2025
Parks Associates has released new data showing that nearly half (45%) of U.S. internet homes watch free ad-supported streaming TV (FAST) services and 89% of U.S...
16/10/2025
TROY, Mich. -New data from J.D. Power's 2025 U.S. Residential Internet Service Provider Study shows that residential wireless internet providers are growing...
15/10/2025
Across the world, early-career reporters are interrogating systems that shape daily life, from mortuaries and classrooms to the corridors of legal education and...
15/10/2025
St. Louis Blues Pay Tribute to Ozzy Osbourne in New Pregame Open VideoThe NHL franchise worked with production firms 2WEI and 4th Floor CreativeBy Mark J Burns,...
15/10/2025
Cobalt Digital, G3DVu, Proxima Vision, and Telos Alliance Renew Premier Sponsors...
15/10/2025
By Paige Bethmann
Before my grandmother passed away in 2019, I went to visit her in the hospital where she'd been for a few weeks. When I arrived, the nurs...
15/10/2025
Two years ago, Spotify set out to grow the entire publishing industry by making ...
15/10/2025
People turn to DJ for a listening experience that feels personal, dynamic, and j...
15/10/2025
Las personas recurren a DJ para vivir una experiencia de escucha personal, din m...
15/10/2025
Rock legend Bruce Springsteen and luminary actor Jeremy Allen White came togethe...
15/10/2025
At Spotify, we're all about supporting rising talent and helping them connec...
15/10/2025
New SBS Documentary Series THE CANCER KILLERS Premieres 4 November on SBS & SBS ...
15/10/2025
SBS celebrates the Festivals of Lights with bold, illuminating stories across th...
15/10/2025
One of humanity's most profound questions continues: Is there any place in our galaxy suitable for life beyond Earth? NASA intends to find out, with the hel...
15/10/2025
eds3_5_jq(document).ready(function($) { $(#eds_sliderM519).chameleonSlider_2_1({ content_source:......
15/10/2025
Scality, a global leader in cyber-resilient storage software for the AI era, today announced the advancement of its comprehensive AI ecosystem certification pro...
15/10/2025
The Hollywood Professional Association (HPA) today unveiled key highlights of the 2026 HPA Tech Retreat, scheduled for Feb. 15 19 at the Westin Rancho Mirage Go...
15/10/2025
At NAB Show New York 2025 (Stand 244), Interra Systems will showcase the future of media QC, monitoring, and captioning, highlighting its award-winning, AI- and...
15/10/2025
Grass Valley today announced that RMC BFM, part of the CMA-CGM Group and France's third-largest private media group, has chosen Grass Valley's productio...
15/10/2025
Appear, the global leader in live production technology, will demonstrate how its powerful hardware and software innovations are shaping the future of hybrid, s...
15/10/2025
Rakim to Join Berklee's Hip-Hop Hall of Fame at Signature Series Concert The rap icon becomes the latest inductee, following luminaries such as Roxanne Sh...
15/10/2025
Berklee Brings Live Music to the Head of the Charles Student artists will perform on multiple riverfront stages during the 60th anniversary of the world's...
15/10/2025
CobbTV, the government access television channel for Cobb County, Ga. recently acquired an automated playout system from Pebble, a global provider of automation...
15/10/2025
OSLO, Norway Appear, the global leader in live production technology, will demonstrate how its powerful hardware and software innovations are shaping the future...
15/10/2025
NEW YORK The NBA is making major changes to the NBA App and NBA TV as it takes control of them from TNT Sports, which has long managed the league's digital ...
15/10/2025
SAN MATEO, Calif. In what promises to be a major expansion of interactive features and personalized content on the DirecTV platform, the operator and Glance hav...
15/10/2025
SAN JOSE, Calif. Roku has launched changes to its user interface (UI) that the streaming platform says will better showcase original programming on the platform...
15/10/2025
LOS ANGELES Software-defined data storage and data services provider OpenDrives has elevated Alex Dunfey to chief technology officer, responsible for driving th...
15/10/2025
Abu Dhabi, UAE October 15, 2025: Space42 (ADX: SPACE42), the UAE-based AI-powe...
15/10/2025
Sheldon Nichols and Will Trickett to find and prepare more classic cars for budget conscious would-be owners from Wiser Films
UKTV have recommissioned the clas...
15/10/2025
Wednesday 15 October 2025
Nick Cave
JPEG (275 KB)
Explore the creative univer...
15/10/2025
Wednesday 15 October 2025
From breaking up with your partner to quitting your job - new polling shows some messages are just too scary to send
Over a fifth (...
15/10/2025
Rohde & Schwarz unveils compact MXO 3 oscilloscopes with 4 and 8 channels: Advan...
15/10/2025
Back to All News
Revenge Series The Resurrected' Captivates Audiences Across Asia
Entertainment
15 October 2025
GlobalTaiwan
Link copied to clipboard
...
15/10/2025
Back to All News
Bringing the Best in VFX and Virtual Production Together as Eyeline
Jeffrey Shapiro
CEO, Eyeline
Business
15 October 2025
GlobalCanadaInd...
15/10/2025
Deployed by Astound Business Solutions, Harmonic's Primary Distribution Solution Ensures Outstanding Video Quality and Seamless Ad Insertion at the Edge
SA...
15/10/2025
Collaboration extends a trusted relationship as RMC BFM invests in scalable, fut...
15/10/2025
Series coming in 2026 stars Tom Vaughan-Lawlor, Justine Mitchell and Jason O'Mara released today
RT today released first look images of new comedy-drama ...
14/10/2025
SVG Europe Summit 2025: All Sessions Now Available to Watch on SVG PLAYNetworking event that preceded IBC2025 shone a light on elite live sports innovation acro...
14/10/2025
SVG Sit-Down: Author Rich Podolsky on Writing Madden & Summerall: How They Revo...
14/10/2025
SVG All-Stars: Michael Reiners, Coordinating Producer, FloRacingThe Illinois State grad steers a vast schedule of motorsports events at tracks across the countr...
14/10/2025
Content protection: Getting the right management for your DRM By Neal Romanek
Friday, October 10, 2025 - 10:11
Print This Story
Eluvio power the EPCR'...
14/10/2025
As League Takes Over Ops, NBA TV and NBA App Add 60 Games, Weekday Studio Show, ...
14/10/2025
Time and effort: World's largest student-led broadcast prepares to go On Air...
14/10/2025
(L-R) Guest, Kimberly Robinson Jones, Geeta Gandbhir, Pamela Dias, and Takema Ro...
14/10/2025
Lossless ist jetzt mit Spotify Premium verf gbar.
Verlustfreies Audio war eine...
14/10/2025
La qualit Lossless est disponible sur Spotify Premium.
Le format sans perte de...
14/10/2025
For the seventh edition of Spotify and FC Barcelona's artist jersey series, ...
Long-acting injectable malaria drug enters first-in-human study Calibr-Skaggs' long-acting injectable (LAI) platform transforms oral malaria treatment atovaquone, aiming for protection from malaria for three months. 
